Oral Peptides Market Report

China Oral Peptides Industry Market Research Report 2023-2029

  • POSTDATE：Aug 16, 2023
  • PAGES：151
  • REPORT CODE：GMM1738677
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Oral Peptides industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Aptalis Pharma

    • Barr Pharmaceuticals

    • AIMM Therapeutics

    • Amarillo Biosciences

    • Avaxia Biologics

    • Biocon

    • AbbVie

    • Arisgen

    • Abbott Laboratories

    • Alchemia

    • Apotex

    • Biodel Inc

    • AstraZeneca

    • Astellas

    • Anthera Pharmaceuticals

    • Alnara Pharmaceuticals

    • Apollo Life Sciences

    By Type:

    • Octreolin

    • Linaclotide

    • Ostora

    • Plecanatide

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Oral Peptides Market Overview 2018-2029

    • 1.1 China Oral Peptides Industry Development Overview

    • 1.2 China Oral Peptides Industry Development History

    • 1.3 China Oral Peptides Industry Market Size (2018-2029)

    • 1.4 China Oral Peptides Market Analysis by Type from Production Side

      • 1.4.1 China Oral Peptides Production Volume, Production Value and Growth Rate of Octreolin (2018-2029)

      • 1.4.2 China Oral Peptides Production Volume, Production Value and Growth Rate of Linaclotide (2018-2029)

      • 1.4.3 China Oral Peptides Production Volume, Production Value and Growth Rate of Ostora (2018-2029)

      • 1.4.4 China Oral Peptides Production Volume, Production Value and Growth Rate of Plecanatide (2018-2029)

    • 1.5 China Oral Peptides Market Analysis by Application from Consumption End

      • 1.5.1 China Oral Peptides Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Oral Peptides Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Oral Peptides Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Oral Peptides Market Analysis by Region

      • 1.6.1 North China Oral Peptides Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Oral Peptides Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Oral Peptides Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Oral Peptides Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Oral Peptides Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Oral Peptides Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Oral Peptides Market Size and Growth Rate from 2018-2029

    Chapter 2 China Oral Peptides Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Oral Peptides Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Oral Peptides Market Status and Competition Analysis in 2023

      • 2.2.3 China Oral Peptides Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Oral Peptides Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Oral Peptides Industry Development

    Chapter 3 Oral PeptidesIndustry Chain Analysis

    • 3.1 Oral Peptides Industry Chain

    • 3.2 Oral Peptides Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Oral Peptides Market

    • 3.3 Oral Peptides Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Oral Peptides Market

    Chapter 4 China Oral Peptides Market, by Type

    • 4.1 China Oral Peptides Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Oral Peptides Total Production Volume and Growth Rate from Production Side

    • 4.5 China Oral Peptides Production Volume and Growth Rate, by Type

      • 4.5.1 China Oral Peptides Production Volume and Growth Rate of Octreolin

      • 4.5.2 China Oral Peptides Production Volume and Growth Rate of Linaclotide

      • 4.5.3 China Oral Peptides Production Volume and Growth Rate of Ostora

      • 4.5.4 China Oral Peptides Production Volume and Growth Rate of Plecanatide

    Chapter 5 China Oral Peptides Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Oral Peptides Total Market Size and Growth Rate from Consumption End

    • 5.5 China Oral Peptides Market Size and Growth Rate, by Application

      • 5.5.1 China Oral Peptides Market Size and Growth Rate of Application 1

      • 5.5.2 China Oral Peptides Market Size and Growth Rate of Application 2

      • 5.5.3 China Oral Peptides Market Size and Growth Rate of Application 3

    Chapter 6 China Oral Peptides Market, by Region

    • 6.1 China Oral Peptides Production Volume and Production Value, by Region

    • 6.2 China Oral Peptides Sales Volume and Sales Value, by Region

    Chapter 7 North China Oral Peptides Market Analysis

    • 7.1 North China Oral Peptides Market, by Type

    • 7.2 North China Oral Peptides Market, by Application

    Chapter 8 Central China Oral Peptides Market Analysis

    • 8.1 Central China Oral Peptides Market, by Type

    • 8.2 Central China Oral Peptides Market, by Application

    Chapter 9 South China Oral Peptides Market Analysis

    • 9.1 South China Oral Peptides Market, by Type

    • 9.2 South China Oral Peptides Market, by Application

    Chapter 10 East China Oral Peptides Market Analysis

    • 10.1 East China Oral Peptides Market, by Type

    • 10.2 East China Oral Peptides Market, by Application

    Chapter 11 Northeast China Oral Peptides Market Analysis

    • 11.1 Northeast China Oral Peptides Market, by Type

    • 11.2 Northeast China Oral Peptides Market, by Application

    Chapter 12 Southwest China Oral Peptides Market Analysis

    • 12.1 Southwest China Oral Peptides Market, by Type

    • 12.2 Southwest China Oral Peptides Market, by Application

    Chapter 13 Northwest China Oral Peptides Market Analysis

    • 13.1 Northwest China Oral Peptides Market, by Type

    • 13.2 Northwest China Oral Peptides Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Aptalis Pharma

        • 14.1.1 Aptalis Pharma Company Profile

        • 14.1.2 Aptalis Pharma Oral Peptides Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Barr Pharmaceuticals

        • 14.2.1 Barr Pharmaceuticals Company Profile

        • 14.2.2 Barr Pharmaceuticals Oral Peptides Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 AIMM Therapeutics

        • 14.3.1 AIMM Therapeutics Company Profile

        • 14.3.2 AIMM Therapeutics Oral Peptides Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Amarillo Biosciences

        • 14.4.1 Amarillo Biosciences Company Profile

        • 14.4.2 Amarillo Biosciences Oral Peptides Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Avaxia Biologics

        • 14.5.1 Avaxia Biologics Company Profile

        • 14.5.2 Avaxia Biologics Oral Peptides Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Biocon

        • 14.6.1 Biocon Company Profile

        • 14.6.2 Biocon Oral Peptides Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 AbbVie

        • 14.7.1 AbbVie Company Profile

        • 14.7.2 AbbVie Oral Peptides Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Arisgen

        • 14.8.1 Arisgen Company Profile

        • 14.8.2 Arisgen Oral Peptides Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Abbott Laboratories

        • 14.9.1 Abbott Laboratories Company Profile

        • 14.9.2 Abbott Laboratories Oral Peptides Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Alchemia

        • 14.10.1 Alchemia Company Profile

        • 14.10.2 Alchemia Oral Peptides Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Apotex

        • 14.11.1 Apotex Company Profile

        • 14.11.2 Apotex Oral Peptides Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Biodel Inc

        • 14.12.1 Biodel Inc Company Profile

        • 14.12.2 Biodel Inc Oral Peptides Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 AstraZeneca

        • 14.13.1 AstraZeneca Company Profile

        • 14.13.2 AstraZeneca Oral Peptides Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Astellas

        • 14.14.1 Astellas Company Profile

        • 14.14.2 Astellas Oral Peptides Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Anthera Pharmaceuticals

        • 14.15.1 Anthera Pharmaceuticals Company Profile

        • 14.15.2 Anthera Pharmaceuticals Oral Peptides Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Alnara Pharmaceuticals

        • 14.16.1 Alnara Pharmaceuticals Company Profile

        • 14.16.2 Alnara Pharmaceuticals Oral Peptides Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Apollo Life Sciences

        • 14.17.1 Apollo Life Sciences Company Profile

        • 14.17.2 Apollo Life Sciences Oral Peptides Market Performance

        • 14.17.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Oral Peptides Industry Research Conclusions

    • 15.2 Oral Peptides Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Oral Peptides Industry Market Size (2018-2029)

    • Figure China Oral Peptides Production Volume, Production Value and Growth Rate of Octreolin (2018-2029)

    • Figure China Oral Peptides Production Volume, Production Value and Growth Rate of Linaclotide (2018-2029)

    • Figure China Oral Peptides Production Volume, Production Value and Growth Rate of Ostora (2018-2029)

    • Figure China Oral Peptides Production Volume, Production Value and Growth Rate of Plecanatide (2018-2029)

    • Figure China Oral Peptides Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Oral Peptides Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Oral Peptides Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Oral Peptides Market Size and Growth Rate from 2018-2029

    • Figure Central China Oral Peptides Market Size and Growth Rate from 2018-2029

    • Figure South China Oral Peptides Market Size and Growth Rate from 2018-2029

    • Figure East China Oral Peptides Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Oral Peptides Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Oral Peptides Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Oral Peptides Market Size and Growth Rate from 2018-2029

    • Figure Oral Peptides Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Oral Peptides Market Share by Type in 2018

    • Figure China Oral Peptides Market Share by Type in 2023

    • Figure China Oral Peptides Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Oral Peptides Production Volume and Growth Rate of Octreolin (2018-2023)

    • Figure China Oral Peptides Production Volume and Growth Rate of Linaclotide (2018-2023)

    • Figure China Oral Peptides Production Volume and Growth Rate of Ostora (2018-2023)

    • Figure China Oral Peptides Production Volume and Growth Rate of Plecanatide (2018-2023)

    • Figure China Oral Peptides Market Share by Application in 2018

    • Figure China Oral Peptides Market Share by Application in 2023

    • Figure China Oral Peptides Total Market Size and Growth Rate from Consumption End

    • Figure China Oral Peptides Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Oral Peptides Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Oral Peptides Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Oral Peptides Production Volume by Region (2018-2023)

    • Table China Oral Peptides Production Volume Share by Region (2018-2023)

    • Figure China Oral Peptides Production Volume Share by Region (2018-2023)

    • Table China Oral Peptides Production Value by Region (2018-2023)

    • Table China Oral Peptides Production Value Share by Region (2018-2023)

    • Figure China Oral Peptides Production Value Share by Region (2018-2023)

    • Table China Oral Peptides Sales Volume by Region (2018-2023)

    • Table China Oral Peptides Sales Volume Share by Region (2018-2023)

    • Figure China Oral Peptides Sales Volume Share by Region (2018-2023)

    • Table China Oral Peptides Sales Value by Region (2018-2023)

    • Table China Oral Peptides Sales Value Share by Region (2018-2023)

    • Figure China Oral Peptides Sales Value Share by Region (2018-2023)

    • Table North China Oral Peptides Production Volume by Type (2018-2023)

    • Table North China Oral Peptides Production Volume Share by Type (2018-2023)

    • Figure North China Oral Peptides Production Volume Share by Type (2018-2023)

    • Table North China Oral Peptides Sales Volume by Application (2018-2023)

    • Table North China Oral Peptides Sales Volume Share by Application (2018-2023)

    • Figure North China Oral Peptides Sales Volume Share by Application (2018-2023)

    • Table Central China Oral Peptides Production Volume by Type (2018-2023)

    • Table Central China Oral Peptides Production Volume Share by Type (2018-2023)

    • Figure Central China Oral Peptides Production Volume Share by Type (2018-2023)

    • Table Central China Oral Peptides Sales Volume by Application (2018-2023)

    • Table Central China Oral Peptides Sales Volume Share by Application (2018-2023)

    • Figure Central China Oral Peptides Sales Volume Share by Application (2018-2023)

    • Table South China Oral Peptides Production Volume by Type (2018-2023)

    • Table South China Oral Peptides Production Volume Share by Type (2018-2023)

    • Figure South China Oral Peptides Production Volume Share by Type (2018-2023)

    • Table South China Oral Peptides Sales Volume by Application (2018-2023)

    • Table South China Oral Peptides Sales Volume Share by Application (2018-2023)

    • Figure South China Oral Peptides Sales Volume Share by Application (2018-2023)

    • Table East China Oral Peptides Production Volume by Type (2018-2023)

    • Table East China Oral Peptides Production Volume Share by Type (2018-2023)

    • Figure East China Oral Peptides Production Volume Share by Type (2018-2023)

    • Table East China Oral Peptides Sales Volume by Application (2018-2023)

    • Table East China Oral Peptides Sales Volume Share by Application (2018-2023)

    • Figure East China Oral Peptides Sales Volume Share by Application (2018-2023)

    • Table Northeast China Oral Peptides Production Volume by Type (2018-2023)

    • Table Northeast China Oral Peptides Production Volume Share by Type (2018-2023)

    • Figure Northeast China Oral Peptides Production Volume Share by Type (2018-2023)

    • Table Northeast China Oral Peptides Sales Volume by Application (2018-2023)

    • Table Northeast China Oral Peptides Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Oral Peptides Sales Volume Share by Application (2018-2023)

    • Table Southwest China Oral Peptides Production Volume by Type (2018-2023)

    • Table Southwest China Oral Peptides Production Volume Share by Type (2018-2023)

    • Figure Southwest China Oral Peptides Production Volume Share by Type (2018-2023)

    • Table Southwest China Oral Peptides Sales Volume by Application (2018-2023)

    • Table Southwest China Oral Peptides Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Oral Peptides Sales Volume Share by Application (2018-2023)

    • Table Northwest China Oral Peptides Production Volume by Type (2018-2023)

    • Table Northwest China Oral Peptides Production Volume Share by Type (2018-2023)

    • Figure Northwest China Oral Peptides Production Volume Share by Type (2018-2023)

    • Table Northwest China Oral Peptides Sales Volume by Application (2018-2023)

    • Table Northwest China Oral Peptides Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Oral Peptides Sales Volume Share by Application (2018-2023)

    • Table Aptalis Pharma Company Profile

    • Table Aptalis Pharma Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table Barr Pharmaceuticals Company Profile

    • Table Barr Pharmaceuticals Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table AIMM Therapeutics Company Profile

    • Table AIMM Therapeutics Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table Amarillo Biosciences Company Profile

    • Table Amarillo Biosciences Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table Avaxia Biologics Company Profile

    • Table Avaxia Biologics Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table Biocon Company Profile

    • Table Biocon Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table Arisgen Company Profile

    • Table Arisgen Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table Alchemia Company Profile

    • Table Alchemia Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table Apotex Company Profile

    • Table Apotex Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table Biodel Inc Company Profile

    • Table Biodel Inc Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table Astellas Company Profile

    • Table Astellas Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table Anthera Pharmaceuticals Company Profile

    • Table Anthera Pharmaceuticals Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table Alnara Pharmaceuticals Company Profile

    • Table Alnara Pharmaceuticals Oral Peptides Revenue, Price and Gross (2018-2023)

    • Table Apollo Life Sciences Company Profile

    • Table Apollo Life Sciences Oral Peptides Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US